BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 28404200)

  • 1. Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study.
    Walter FM; Mills K; Mendonça SC; Abel GA; Basu B; Carroll N; Ballard S; Lancaster J; Hamilton W; Rubin GP; Emery JD
    Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):298-306. PubMed ID: 28404200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding symptom appraisal and help-seeking in people with symptoms suggestive of pancreatic cancer: a qualitative study.
    Mills K; Birt L; Emery JD; Hall N; Banks J; Johnson M; Lancaster J; Hamilton W; Rubin GP; Walter FM
    BMJ Open; 2017 Sep; 7(9):e015682. PubMed ID: 28871013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptoms and patient factors associated with longer time to diagnosis for colorectal cancer: results from a prospective cohort study.
    Walter FM; Emery JD; Mendonca S; Hall N; Morris HC; Mills K; Dobson C; Bankhead C; Johnson M; Abel GA; Rutter MD; Hamilton W; Rubin GP
    Br J Cancer; 2016 Aug; 115(5):533-41. PubMed ID: 27490803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.
    Raptis DA; Fessas C; Belasyse-Smith P; Kurzawinski TR
    Surgeon; 2010 Oct; 8(5):239-46. PubMed ID: 20709279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic timeliness in adolescents and young adults with cancer: a cross-sectional analysis of the BRIGHTLIGHT cohort.
    Herbert A; Lyratzopoulos G; Whelan J; Taylor RM; Barber J; Gibson F; Fern LA
    Lancet Child Adolesc Health; 2018 Mar; 2(3):180-190. PubMed ID: 29503844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms and other factors associated with time to diagnosis and stage of lung cancer: a prospective cohort study.
    Walter FM; Rubin G; Bankhead C; Morris HC; Hall N; Mills K; Dobson C; Rintoul RC; Hamilton W; Emery J
    Br J Cancer; 2015 Mar; 112 Suppl 1(Suppl 1):S6-13. PubMed ID: 25734397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic delay does not influence survival of pancreatic cancer patients.
    Stornello C; Archibugi L; Stigliano S; Vanella G; Graglia B; Capalbo C; Nigri G; Capurso G
    United European Gastroenterol J; 2020 Feb; 8(1):81-90. PubMed ID: 32213057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Care pathway of patients with metastatic pancreatic cancer in daily practice in France: Results from the REPERE national survey.
    Hammel P; Coriat R; Lledo G; de Bausset M; Selosse M; Obled S; Bonnetain F
    Bull Cancer; 2017 Apr; 104(4):321-331. PubMed ID: 28087054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agreement between patient-reported and doctor-reported patient intervals and date of first symptom presentation in cancer diagnosis - a population-based questionnaire study.
    Larsen MB; Hansen RP; Sokolowski I; Vedsted P
    Cancer Epidemiol; 2014 Feb; 38(1):100-5. PubMed ID: 24238619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic factors and trajectory of HRQOL in patients with pancreatic cancer who received psychiatric intervention.
    Sugimoto H; Kawashima H; Ohno E; Hayashi D; Kuwahara T; Morishima T; Kawai M; Suhara H; Takeyama T; Yamamura T; Funasaka K; Nakamura M; Miyahara R; Watanabe O; Ishigami M; Suzuki M; Kimura H; Ozaki N; Hashimoto S; Goto H; Hirooka Y
    J Gastroenterol Hepatol; 2016 Mar; 31(3):685-90. PubMed ID: 26412310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area.
    Holly EA; Chaliha I; Bracci PM; Gautam M
    Clin Gastroenterol Hepatol; 2004 Jun; 2(6):510-7. PubMed ID: 15181621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care.
    Tørring ML; Frydenberg M; Hansen RP; Olesen F; Vedsted P
    Eur J Cancer; 2013 Jun; 49(9):2187-98. PubMed ID: 23453935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and Gender Variations in Cancer Diagnostic Intervals in 15 Cancers: Analysis of Data from the UK Clinical Practice Research Datalink.
    Din NU; Ukoumunne OC; Rubin G; Hamilton W; Carter B; Stapley S; Neal RD
    PLoS One; 2015; 10(5):e0127717. PubMed ID: 25978414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of advanced stage colorectal cancer with longer diagnostic intervals: a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries.
    Tørring ML; Murchie P; Hamilton W; Vedsted P; Esteva M; Lautrup M; Winget M; Rubin G
    Br J Cancer; 2017 Sep; 117(6):888-897. PubMed ID: 28787432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time intervals from first symptom to diagnosis for head and neck cancers: An analysis of linked patient reports and medical records from the UK.
    Allgar VL; Oliver SE; Chen H; Oviasu O; Johnson MJ; Macleod U
    Cancer Epidemiol; 2019 Apr; 59():37-45. PubMed ID: 30669114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferences for cancer investigation: a vignette-based study of primary-care attendees.
    Banks J; Hollinghurst S; Bigwood L; Peters TJ; Walter FM; Hamilton W
    Lancet Oncol; 2014 Feb; 15(2):232-40. PubMed ID: 24433682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of symptoms for ovarian cancer: comparison of symptoms reported by questionnaire, interview, and general practitioner notes.
    Lim AW; Mesher D; Gentry-Maharaj A; Balogun N; Jacobs I; Menon U; Sasieni P
    J Natl Cancer Inst; 2012 Jan; 104(2):114-24. PubMed ID: 22247022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer symptom trajectories from Danish registry data and free text in electronic health records.
    Hjaltelin JX; Novitski SI; Jørgensen IF; Siggaard T; Vulpius SA; Westergaard D; Johansen JS; Chen IM; Juhl Jensen L; Brunak S
    Elife; 2023 Nov; 12():. PubMed ID: 37988407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP).
    Weller D; Menon U; Zalounina Falborg A; Jensen H; Barisic A; Knudsen AK; Bergin RJ; Brewster DH; Cairnduff V; Gavin AT; Grunfeld E; Harland E; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Harrison S; Reguilon I; ; Vedsted P
    BMJ Open; 2018 Nov; 8(11):e023870. PubMed ID: 30482749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study.
    Koo MM; Swann R; McPhail S; Abel GA; Elliss-Brookes L; Rubin GP; Lyratzopoulos G
    Lancet Oncol; 2020 Jan; 21(1):73-79. PubMed ID: 31704137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.